Aurora Cannabis stock rises in premarket on narrower loss from the year-ago period
259.17MUSD
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
CA05156X8843
CUSIP
05156X108
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
March
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
0.01
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.46
Wall Street Target Price
32.07
EPS Estimate Current Year
-0.92
EPS Estimate Next Year
-0.46
EPS Estimate Current Quarter
-0.35
EPS Estimate Next Quarter
-0.33
Most Recent Quarter
-
Revenue TTM
296,987,008
Gross Profit TTM
21,225,000
EBITDA
10,308,000
Profit Margin
-14.71%
Return On Assets TTM
-1.24%
Return On Equity TTM
-5.79%
Revenue Per Share TTM
0.033
Qtly Revenue Growth YOY
28.50%
Diluted Eps TTM
-0.46
Qtly Earnings Growth YOY
-91.70%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
0.8381
Price Book MRQ
0.6361
Enterprise Value Revenue
1
Enterprise Value EBITDA
96
27.37
2.70%17.65
1.82%179.14
1.54%43.69
1.36%148.21
1.20%12.82
0.90%13.75
0.11%17.50
-2.78%29.36
-0.37%9.65
-0.16%Aurora Cannabis stock rises in premarket on narrower loss from the year-ago period